These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 10488950

  • 1. Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions.
    Millar JS, Anber V, Shepherd J, Packard CJ.
    Atherosclerosis; 1999 Aug; 145(2):253-60. PubMed ID: 10488950
    [Abstract] [Full Text] [Related]

  • 2. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.
    Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2507-14. PubMed ID: 9409221
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins.
    Bradley WA, Hwang SL, Karlin JB, Lin AH, Prasad SC, Gotto AM, Gianturco SH.
    J Biol Chem; 1984 Dec 10; 259(23):14728-35. PubMed ID: 6501314
    [Abstract] [Full Text] [Related]

  • 5. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
    Demant T, Bedford D, Packard CJ, Shepherd J.
    J Clin Invest; 1991 Nov 10; 88(5):1490-501. PubMed ID: 1939641
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
    Demant T, Gaw A, Watts GF, Durrington P, Buckley B, Imrie CW, Wilson C, Packard CJ, Shepherd J.
    J Lipid Res; 1993 Jan 10; 34(1):147-56. PubMed ID: 8445339
    [Abstract] [Full Text] [Related]

  • 7. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES, Tikkanen MJ, Cole TG, Davie JM, Schonfeld G.
    J Clin Invest; 1985 Feb 10; 75(2):361-9. PubMed ID: 3973009
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of simvastatin on apoB metabolism and LDL subfraction distribution.
    Gaw A, Packard CJ, Murray EF, Lindsay GM, Griffin BA, Caslake MJ, Vallance BD, Lorimer AR, Shepherd J.
    Arterioscler Thromb; 1993 Feb 10; 13(2):170-89. PubMed ID: 8427854
    [Abstract] [Full Text] [Related]

  • 10. Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia.
    Bruckert E, Dejager S, Chapman MJ.
    Atherosclerosis; 1993 Apr 10; 100(1):91-102. PubMed ID: 8318067
    [Abstract] [Full Text] [Related]

  • 11. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028
    [Abstract] [Full Text] [Related]

  • 12. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
    Guerin M, Le Goff W, Frisdal E, Schneider S, Milosavljevic D, Bruckert E, Chapman MJ.
    J Clin Endocrinol Metab; 2003 Aug 24; 88(8):3738-46. PubMed ID: 12915663
    [Abstract] [Full Text] [Related]

  • 13. Statin treatment increases the sialic acid content of LDL in hypercholesterolemic patients.
    Lindbohm N, Gylling H, Miettinen TE, Miettinen TA.
    Atherosclerosis; 2000 Aug 24; 151(2):545-50. PubMed ID: 10924733
    [Abstract] [Full Text] [Related]

  • 14. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans.
    Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J.
    Atherosclerosis; 1996 Aug 02; 124(2):261-71. PubMed ID: 8830938
    [Abstract] [Full Text] [Related]

  • 15. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D, Griglio S, Le Naour G, Chapman MJ.
    Atherosclerosis; 2001 Mar 02; 155(1):251-60. PubMed ID: 11223449
    [Abstract] [Full Text] [Related]

  • 16. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    Tertov VV, Kaplun VV, Sobenin IA, Orekhov AN.
    Atherosclerosis; 1998 May 02; 138(1):183-95. PubMed ID: 9678784
    [Abstract] [Full Text] [Related]

  • 17. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
    Kontopoulos AG, Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Mayroudi MC, Boudoulas H.
    Coron Artery Dis; 1996 Nov 02; 7(11):843-50. PubMed ID: 8993943
    [Abstract] [Full Text] [Related]

  • 18. Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function.
    Marcel YL, Hogue M, Weech PK, Davignon J, Milne RW.
    Arteriosclerosis; 1988 Nov 02; 8(6):832-44. PubMed ID: 2461695
    [Abstract] [Full Text] [Related]

  • 19. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N, Devaraj SN, Devaraj H.
    Eur J Nutr; 2003 Oct 02; 42(5):262-71. PubMed ID: 14569407
    [Abstract] [Full Text] [Related]

  • 20. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug 02; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.